Can intensive statin therapy cause regression of coronary atherosclerosis?
David E Newby
Correspondence Room SU314 Chancellor's Building University of Edinburgh Royal Infirmary, 49 Little France Crescent, Little France, Edinburgh EH16 4SA, UK
Email d.e.newby@ed.ac.uk
This article has no abstract so we have provided the first paragraph of the full text.
Atherosclerosis is the predominant cause of cardiovascular disease and death in modern society. Advances in treatment over the last 30 years have led to the use of aspirin, statin and angiotensin-converting-enzyme inhibitor therapy in the prevention of atherosclerotic disease. These advances have resulted in major individual and societal benefits, with substantial reductions in cardiovascular morbidity and mortality.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
